Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 144.86

+0.5%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Billy Dunn who started this subject	5/21/2001 8:18:00 AM
From: Icebrg	Read Replies (1) of 1834

7:48AM Neurocrine Biosci (NBIX) 31.44: Robertson Stephens upgrades to STRONG BUY from Buy and arrives a one yr price target of $61; expects NBIX to become a late-stage product story in Q3 as it initiates Phase III clinical trials of its insomnia compound.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next